Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-05-05 | Vincent Joseph SandsInsider | -28,18k | 3,31k | Verkauf | 0,12 | 0,00 | -100,00% |
| 2026-05-05 | Ms. Jie ZhangCFO | -28,18k | 3,31k | Verkauf | 0,12 | 0,00 | -100,00% |
| 2026-02-18 | Ms. Jie ZhangCFO | 28,18k | 2,89k | Derivative Exercise and Retained Stock | 0,10 | 28,18k | - |
| 2026-02-18 | Vincent Joseph SandsInsider | 28,18k | 2,89k | Derivative Exercise and Retained Stock | 0,10 | 28,18k | - |
| 2025-12-17 | Mr. Samuel Thomas MawbyManaging Director of Europe | -78,19k | 7,47k | Verkauf | 0,10 | 174,00k | -31,00% |
| 2025-12-17 | Ms. Isobel WalesInsider | -78,19k | 7,47k | Verkauf | 0,10 | 58,50k | -57,20% |
| 2025-12-17 | Vincent Joseph SandsInsider | -78,19k | 7,47k | Verkauf | 0,10 | 0,00 | -100,00% |
| 2025-11-30 | Mr. Robert W. TriebeCOO | 1.000,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 0,09 | 2,25M | 79,74% |
| 2025-11-30 | Mr. William M. CrosslandPresident, CEO & Director | 1.000,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 0,09 | 2,67M | 59,81% |
| 2025-11-30 | Mr. Samuel Thomas MawbyManaging Director of Europe | 249,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 0,09 | 1,17M | 27,15% |
| 2025-11-30 | Dr. David SpagnoloIndependent Director | 250,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 0,09 | 250,00k | - |
| 2025-11-30 | Ms. Isobel WalesInsider | 168,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 0,09 | 1,00M | 20,10% |
| 2025-11-30 | Ms. Jie ZhangCFO | 168,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 0,09 | 1,00M | 20,10% |
| 2025-11-30 | Vincent Joseph SandsInsider | 249,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 0,09 | 1,14M | 28,07% |
| 2025-11-25 | Mr. William M. CrosslandPresident, CEO & Director | 500,00k | 31,89k | Derivative Exercise and Retained Stock | 0,06 | 10,26M | 5,12% |
| 2025-11-12 | Mr. Samuel Thomas MawbyManaging Director of Europe | 78,19k | 5,03k | Derivative Exercise and Retained Stock | 0,06 | 252,19k | 44,94% |
| 2025-11-12 | Dr. David SpagnoloIndependent Director | 250,00k | 16,07k | Derivative Exercise and Retained Stock | 0,06 | 520,00k | 92,59% |
| 2025-11-12 | Ms. Isobel WalesInsider | 78,19k | 5,03k | Derivative Exercise and Retained Stock | 0,06 | 136,69k | 133,65% |
| 2025-11-12 | Vincent Joseph SandsInsider | 78,19k | 5,03k | Derivative Exercise and Retained Stock | 0,06 | 78,19k | - |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
